Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency.

Cohen-Cymberknoh M, Atia O, Gileles-Hillel A, Kerem E, Reiter J.

Respir Med. 2019 May;151:96-101. doi: 10.1016/j.rmed.2019.03.022. Epub 2019 Apr 5.

PMID:
31047123
2.

Giant lung cysts following necrotizing pneumonia: Resolution with conservative treatment.

Gross I, Gordon O, Cohen-Cymberknoh M, Reiter J, Tsabari R, Gileles-Hillel A, Erlichman I, Hevroni A, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2019 Jun;54(6):901-906. doi: 10.1002/ppul.24321. Epub 2019 Mar 21.

PMID:
30897292
3.

Failure to conceive in women with CF is associated with pancreatic insufficiency and advancing age.

Shteinberg M, Lulu AB, Downey DG, Blumenfeld Z, Rousset-Jablonski C, Perceval M, Colombo A, Stein N, Livnat G, Gur M, Bentur L, Mussaffi H, Blau H, Sarouk I, Dagan A, Kerem E, Aviram M, Picard E, Aliberti S, Álvarez A, Miranda JP, Polverino E, Durieu I, Stuart Elborn J, Cohen-Cymberknoh M.

J Cyst Fibros. 2019 Jul;18(4):525-529. doi: 10.1016/j.jcf.2018.10.009. Epub 2018 Oct 23.

PMID:
30366850
4.

Increasing Vitamin D Serum Levels Is Associated With Reduced Pulmonary Exacerbations in Patients With Cystic Fibrosis.

Abu-Fraiha Y, Elyashar-Earon H, Shoseyov D, Cohen-Cymberknoh M, Armoni S, Kerem E, Wilschanski M.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):110-115. doi: 10.1097/MPG.0000000000002126.

PMID:
30095576
5.

Primary sclerosing cholangitis is associated with abnormalities in CFTR.

Werlin S, Scotet V, Uguen K, Audrezet MP, Cohen M, Yaakov Y, Safadi R, Ilan Y, Konikoff F, Galun E, Mizrahi M, Slae M, Sayag S, Cohen-Cymberknoh M, Wilschanski M, Ferec C.

J Cyst Fibros. 2018 Sep;17(5):666-671. doi: 10.1016/j.jcf.2018.04.005. Epub 2018 May 26.

PMID:
29807875
6.

A quality improvement intervention to reduce emergency department radiography for bronchiolitis.

Reiter J, Breuer A, Breuer O, Hashavya S, Rekhtman D, Kerem E, Cohen-Cymberknoh M.

Respir Med. 2018 Apr;137:1-5. doi: 10.1016/j.rmed.2018.02.014. Epub 2018 Feb 19.

PMID:
29605191
7.

Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis.

Cohen-Cymberknoh M, Tanny T, Breuer O, Blau H, Mussaffi H, Kadosh D, Gartner S, Salinas A, Bentur L, Nir V, Gur M, Reiter J, Shoseyov D, Kerem E, Berger I.

J Cyst Fibros. 2018 Mar;17(2):281-285. doi: 10.1016/j.jcf.2017.11.020. Epub 2017 Dec 19.

PMID:
29269187
8.

Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.

Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, De Boeck K, Barbato A, Snijders D, Collura M, Pradal U, Blau H, Mussaffi H, Price M, Bentur L, Gur M, Aviram M, Picard E, Shteinberg M, Livnat G, Rivlin J, Hiller N, Shoseyov D, Amirav I, Kerem E.

Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.

PMID:
28947038
9.

Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.

Dagan A, Cohen-Cymberknoh M, Shteinberg M, Levine H, Vilozni D, Bezalel Y, Bar Aluma BE, Sarouk I, Ashkenazi M, Lavie M, Tsabari R, Blau H, Kerem E, Bentur L, Efrati O, Livnat G.

Respir Med. 2017 Oct;131:225-228. doi: 10.1016/j.rmed.2017.08.026. Epub 2017 Sep 1.

PMID:
28947035
10.

Predictors of Prolonged Hospitalizations in Pediatric Complicated Pneumonia.

Breuer O, Picard E, Benabu N, Erlichman I, Reiter J, Tsabari R, Shoseyov D, Kerem E, Cohen-Cymberknoh M.

Chest. 2018 Jan;153(1):172-180. doi: 10.1016/j.chest.2017.09.021. Epub 2017 Sep 21.

PMID:
28943281
11.

Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Behar DM, Inbar O, Shteinberg M, Gur M, Mussaffi H, Shoseyov D, Ashkenazi M, Alkrinawi S, Bormans C, Hakim F, Mei-Zahav M, Cohen-Cymberknoh M, Dagan A, Prais D, Sarouk I, Stafler P, Bar Aluma BE, Akler G, Picard E, Aviram M, Efrati O, Livnat G, Rivlin J, Bentur L, Blau H, Kerem E, Singer A.

Mol Genet Genomic Med. 2017 Feb 19;5(3):223-236. doi: 10.1002/mgg3.278. eCollection 2017 May.

12.

Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.

Breuer O, Daum H, Cohen-Cymberknoh M, Unger S, Shoseyov D, Stepensky P, Keller B, Warnatz K, Kerem E.

Respir Med. 2017 May;126:39-45. doi: 10.1016/j.rmed.2017.03.018. Epub 2017 Mar 22.

13.

Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Amirav I, Roduta Roberts M, Mussaffi H, Mandelberg A, Roth Y, Abitbul R, Luder A, Blau H, Alkrinawi S, Aviram M, Ben-Ami M, Rotschild M, Bentur L, Shoseyov D, Cohen-Cymberknoh M, Kerem E, Avital A, Springer C, Hevroni A, Dabbah H, Elizur A, Picard E, Goldberg S, Rivlin J, Livnat G, Lavie M, Alias N, Soferman R, Olbrich H, Raidt J, Wallmeier J, Werner C, Loges NT, Omran H.

Version 2. F1000Res. 2016 Aug 18 [revised 2016 Jan 1];5:2031. eCollection 2016.

14.

Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function.

Wilschanski M, Yaakov Y, Omari I, Zaman M, Martin CR, Cohen-Cymberknoh M, Shoseyov D, Kerem E, Dasilva D, Sheth S, Uluer A, OʼSullivan BP, Freedman S.

J Pediatr Gastroenterol Nutr. 2016 Nov;63(5):e92-e97.

PMID:
27496797
15.

Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.

Abitbul R, Amirav I, Blau H, Alkrinawi S, Aviram M, Shoseyov D, Bentur L, Avital A, Springer C, Lavie M, Prais D, Dabbah H, Elias N, Elizur A, Goldberg S, Hevroni A, Kerem E, Luder A, Roth Y, Cohen-Cymberknoh M, Ben Ami M, Mandelberg A, Livnat G, Picard E, Rivlin J, Rotschild M, Soferman R, Loges NT, Olbrich H, Werner C, Wolter A, Herting M, Wallmeier J, Raidt J, Omran H, Mussaffi H.

Respir Med. 2016 Oct;119:41-47. doi: 10.1016/j.rmed.2016.08.015. Epub 2016 Aug 23.

16.

Complicated community acquired pneumonia in childhood: Different types, clinical course, and outcome.

Erlichman I, Breuer O, Shoseyov D, Cohen-Cymberknoh M, Koplewitz B, Averbuch D, Erlichman M, Picard E, Kerem E.

Pediatr Pulmonol. 2017 Feb;52(2):247-254. doi: 10.1002/ppul.23523. Epub 2016 Jul 8.

PMID:
27392317
17.

Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.

Cohen-Cymberknoh M, Gilead N, Gartner S, Rovira S, Blau H, Mussaffi H, Rivlin J, Gur M, Shteinberg M, Bentur L, Livnat G, Aviram M, Picard E, Tenenbaum A, Armoni S, Breuer O, Shoseyov D, Kerem E.

J Cyst Fibros. 2016 Nov;15(6):776-782. doi: 10.1016/j.jcf.2016.04.006. Epub 2016 May 1.

18.

Treatment of cystic fibrosis in low-income countries.

Cohen-Cymberknoh M, Shoseyov D, Breuer O, Shamali M, Wilschanski M, Kerem E.

Lancet Respir Med. 2016 Feb;4(2):91-2. doi: 10.1016/S2213-2600(15)00507-X. No abstract available.

PMID:
26868623
19.

Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease.

Breuer O, Shteyer E, Wilschanski M, Perles Z, Cohen-Cymberknoh M, Kerem E, Shoseyov D.

Chest. 2016 Feb;149(2):e35-e38. doi: 10.1016/j.chest.2015.10.040.

20.

Disparities in Cystic Fibrosis Care and Outcome: Socioeconomic Status and Beyond.

Kerem E, Cohen-Cymberknoh M.

Chest. 2016 Feb;149(2):298-300. doi: 10.1016/j.chest.2015.08.021. No abstract available.

PMID:
26867826
21.

Ataluren for the treatment of cystic fibrosis.

Shoseyov D, Cohen-Cymberknoh M, Wilschanski M.

Expert Rev Respir Med. 2016 Apr;10(4):387-391. doi: 10.1586/17476348.2016.1150181. Epub 2016 Feb 24.

PMID:
26840186
22.

Reversible airway obstruction in cystic fibrosis: Common, but not associated with characteristics of asthma.

Levine H, Cohen-Cymberknoh M, Klein N, Hoshen M, Mussaffi H, Stafler P, Breuer O, Kerem E, Blau H.

J Cyst Fibros. 2016 Sep;15(5):652-9. doi: 10.1016/j.jcf.2016.01.003. Epub 2016 Jan 28.

23.

Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.

Pugatsch T, Shoseyov D, Cohen-Cymberknoh M, Hayut B, Armoni S, Griese M, Kerem E.

Pediatr Pulmonol. 2016 Feb;51(2):143-6. doi: 10.1002/ppul.23344. Epub 2015 Nov 19.

PMID:
26583331
24.

The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.

Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H.

J Cyst Fibros. 2016 Jul;15(4):460-6. doi: 10.1016/j.jcf.2015.08.007. Epub 2015 Sep 16.

25.

Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.

Gileles-Hillel A, Shoseyov D, Polacheck I, Korem M, Kerem E, Cohen-Cymberknoh M.

Pediatr Pulmonol. 2015 Nov;50(11):1082-9. doi: 10.1002/ppul.23302. Epub 2015 Sep 18.

PMID:
26383963
26.

Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.

Breuer O, Blich O, Cohen-Cymberknoh M, Averbuch D, Kharasch S, Shoseyov D, Kerem E.

Pediatr Pulmonol. 2015 May;50(5):495-502. doi: 10.1002/ppul.23159. Epub 2015 Feb 4.

PMID:
25652187
27.

Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O.

World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.

28.

Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.

Breuer O, Cohen-Cymberknoh M, Armoni S, Kerem E, Shoseyov D.

Ann Allergy Asthma Immunol. 2014 Aug;113(2):229-30. doi: 10.1016/j.anai.2014.05.014. Epub 2014 Jun 13. No abstract available.

PMID:
24934107
29.

Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency.

Cohen-Cymberknoh M, Simanovsky N, Hiller N, Hillel AG, Shoseyov D, Kerem E.

Chest. 2014 Apr;145(4):738-744. doi: 10.1378/chest.13-1162.

PMID:
24091606
30.

CCDC65 mutation causes primary ciliary dyskinesia with normal ultrastructure and hyperkinetic cilia.

Horani A, Brody SL, Ferkol TW, Shoseyov D, Wasserman MG, Ta-shma A, Wilson KS, Bayly PV, Amirav I, Cohen-Cymberknoh M, Dutcher SK, Elpeleg O, Kerem E.

PLoS One. 2013 Aug 26;8(8):e72299. doi: 10.1371/journal.pone.0072299. eCollection 2013.

31.

Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.

Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A.

Thorax. 2013 Dec;68(12):1157-62. doi: 10.1136/thoraxjnl-2013-203204. Epub 2013 May 23. Review.

PMID:
23704228
32.

Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment.

Negari SB, Aouizerat T, Tenenbaum A, Cohen-Cymberknoh M, Shoseyov D, Kerem E, Saada A.

J Cyst Fibros. 2013 Dec;12(6):682-7. doi: 10.1016/j.jcf.2013.04.006. Epub 2013 May 13.

33.

LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects.

Horani A, Ferkol TW, Shoseyov D, Wasserman MG, Oren YS, Kerem B, Amirav I, Cohen-Cymberknoh M, Dutcher SK, Brody SL, Elpeleg O, Kerem E.

PLoS One. 2013;8(3):e59436. doi: 10.1371/journal.pone.0059436. Epub 2013 Mar 19.

34.

Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency.

Simanovsky N, Cohen-Cymberknoh M, Shoseyov D, Gileles-Hillel A, Wilschanski M, Kerem E, Hiller N.

Chest. 2013 Jul;144(1):208-214. doi: 10.1378/chest.12-1226.

PMID:
23392565
35.

Evaluation of the intestinal current measurement method as a diagnostic test for cystic fibrosis.

Cohen-Cymberknoh M, Yaakov Y, Shoseyov D, Shteyer E, Schachar E, Rivlin J, Bentur L, Picard E, Aviram M, Israeli E, Kerem E, Wilschanski M.

Pediatr Pulmonol. 2013 Mar;48(3):229-35. doi: 10.1002/ppul.22586. Epub 2012 May 2.

PMID:
22553157
36.

Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.

Dinur-Schejter Y, Cohen-Cymberknoh M, Tenenbaum A, Brooks R, Averbuch D, Kharasch S, Kerem E.

Pediatr Pulmonol. 2013 Jan;48(1):52-8. doi: 10.1002/ppul.22534. Epub 2012 Mar 19.

PMID:
22431471
37.

Could you please pass the salt?

Shoseyov D, Cohen-Cymberknoh M, Kerem E.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1444-6. doi: 10.1164/rccm.201102-0351ED. No abstract available.

PMID:
21642252
38.

Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.

Cohen-Cymberknoh M, Shoseyov D, Kerem E.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1463-71. doi: 10.1164/rccm.201009-1478CI. Epub 2011 Feb 17. Review.

PMID:
21330455
39.

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.

Wilschanski M, Miller LL, Shoseyov D, Blau H, Rivlin J, Aviram M, Cohen M, Armoni S, Yaakov Y, Pugatsch T, Cohen-Cymberknoh M, Miller NL, Reha A, Northcutt VJ, Hirawat S, Donnelly K, Elfring GL, Ajayi T, Kerem E.

Eur Respir J. 2011 Jul;38(1):59-69. doi: 10.1183/09031936.00120910. Epub 2011 Jan 13. Erratum in: Eur Respir J. 2011 Oct;38(4):996. Pugatch, T [corrected to Pugatsch, T].

40.

Late-onset central hypoventilation presenting as extubation failure.

Cohen-Cymberknoh M, Shoseyov D, Goldberg S, Gross E, Amiel J, Kerem E.

Isr Med Assoc J. 2010 Apr;12(4):249-50. No abstract available.

41.

18F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis.

Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, Freedman N, Kerem E.

Chest. 2009 Nov;136(5):1220-1228. doi: 10.1378/chest.09-0610. Epub 2009 Aug 20.

PMID:
19696124
42.

Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.

Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):173-8. doi: 10.1097/MPG.0b013e3181a3bfdd.

PMID:
19668004
43.

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.

Cohen-Cymberknoh M, Blau H, Shoseyov D, Mei-Zahav M, Efrati O, Armoni S, Kerem E.

J Cyst Fibros. 2009 Jul;8(4):253-7. doi: 10.1016/j.jcf.2009.04.008. Epub 2009 May 15.

44.

Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis.

Amirav I, Cohen-Cymberknoh M, Shoseyov D, Kerem E.

Paediatr Respir Rev. 2009 Jun;10(2):58-62. doi: 10.1016/j.prrv.2008.11.003. Epub 2009 Apr 9. Review.

PMID:
19410203
45.

Concomitant cystic fibrosis and coeliac disease: reminder of an important clinical lesson.

Cohen-Cymberknoh M, Wilschanski M.

BMJ Case Rep. 2009;2009. pii: bcr07.2008.0578. doi: 10.1136/bcr.07.2008.0578. Epub 2009 Mar 5.

Supplemental Content

Loading ...
Support Center